MedicationUse-v3.0(2016EN): verschil tussen versies

Uit Zorginformatiebouwstenen
Naar navigatie springen Naar zoeken springen
(Nieuwe pagina aangemaakt met '==General information== Name: '''nl.zorg.MedicationUse''' link=MedicatieGebruik-v3.0(2016NL)<BR> Version: '''3.0''' <br> HCIM Status:Final<br>...')
 
Geen bewerkingssamenvatting
Regel 3: Regel 3:
Version: '''3.0''' <br>
Version: '''3.0''' <br>
HCIM Status:Final<br>
HCIM Status:Final<br>
Publication: '''2016''' <br>
Release: '''2016''' <br>
Release status: Published<br>
Release status: Published<br>
Publication date: 1-5-2016
Release date: 1-5-2016
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2016(EN)]] [[HCIM_Release_2016(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2016(EN)]] [[HCIM_Release_2016(EN) |Back to HCIM list ]]</div>
Regel 122: Regel 122:
==Information Model==
==Information Model==
<BR>
<BR>
[[Bestand: MedicationUse-v3.0Model(EN).png | center]]
<imagemap> Bestand:MedicationUse-v3.0Model(EN).png | center  
rect 679 205 847 274 [[MedicationPrescription-v3.0(2016EN)]]
rect 251 46 424 116 [[MedicationPrescription-v3.0(2016EN)]]
rect 423 205 545 275 [[#11150]]
rect 70 497 332 547 [[#MedicationUseReasonForInterruptionCodelist]]
rect 97 407 306 477 [[#11158]]
rect 359 497 601 547 [[#MedicationUseReasonForDiscontinuationCodelist]]
rect 388 407 573 477 [[#11159]]
rect 650 497 831 547 [[#MedicationUseStatusCodelist]]
rect 540 46 732 116 [[MedicationPrescription-v3.0(2016EN)]]
rect 679 407 801 477 [[#11154]]
rect 149 205 271 275 [[#11863]]
desc none
</imagemap>
<BR>
<BR>
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
{| border= "1"  width="1500px" style = "font-size: 9.5pt;  border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"  
Regel 128: Regel 141:
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px]]
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:9.2.1
||NL-CM:9.2.1
|colspan ="6" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px]]MedicationUse</span>
|colspan ="6" style ="padding-left: 0px"|<span Id=11150 Title="NL: MedicatieGebruik">[[Bestand: arrowdown.png | 10px | link=]]MedicationUse</span>
|
|
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
|Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
Regel 136: Regel 149:
|
|
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.2.2
||NL-CM:9.2.2
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruiksProduct::Product">[[Bestand: arrowright.png | 10px]]ProductUsed::Product</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11151 Title="NL: GebruiksProduct::Product">[[Bestand: arrowright.png | 10px | link=]]ProductUsed::Product</span>
|1
|1
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.  
|The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.  
Regel 149: Regel 162:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|[[Bestand: block.png | link=MedicationPrescription-v3.0(2016EN)]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.2.3
||NL-CM:9.2.3
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Voorschrift::MedicatieVoorschrift">[[Bestand: arrowright.png | 10px]]Prescription</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11155 Title="NL: Voorschrift::MedicatieVoorschrift">[[Bestand: arrowright.png | 10px | link=]]Prescription</span>
|0..*
|0..*
|The agreement or order for the use of medication.
|The agreement or order for the use of medication.
Regel 162: Regel 175:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|[[Bestand: block.png | link=MedicationPrescription-v3.0(2016EN)]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px]]
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.2.4
||NL-CM:9.2.4
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: GebruiksDosering::Dosering">[[Bestand: arrowright.png | 10px]]UsedDosage::Dosage</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11153 Title="NL: GebruiksDosering::Dosering">[[Bestand: arrowright.png | 10px | link=]]UsedDosage::Dosage</span>
|0..*
|0..*
|When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider.  
|When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider.  
Regel 178: Regel 191:
{|
{|
|-
|-
|[[Bestand: block.png]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|[[Bestand: block.png | link=MedicationPrescription-v3.0(2016EN)]]||[[MedicationPrescription-v3.0(2016EN) |MedicationPrescription]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.2.5
||NL-CM:9.2.5
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikStatus">[[Bestand: arrowright.png | 10px]]MedicationUseStatus</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11154 Title="NL: MedicatieGebruikStatus">[[Bestand: arrowright.png | 10px | link=]]MedicationUseStatus</span>
|1
|1
|The status or status code is important in indicating the use schedule.   
|The status or status code is important in indicating the use schedule.   
Regel 202: Regel 215:
{|
{|
|-
|-
|[[Bestand: List2.png]]||[[#MedicationUseStatusCodelist|MedicationUseStatusCodelist]]
|[[Bestand: List2.png | link=#MedicationUseStatusCodelist]]||[[#MedicationUseStatusCodelist|MedicationUseStatusCodelist]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.2.6
||NL-CM:9.2.6
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikRedenVanStoppen">[[Bestand: arrowright.png | 10px]]MedicationUseReasonForDiscontinuation</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11159 Title="NL: MedicatieGebruikRedenVanStoppen">[[Bestand: arrowright.png | 10px | link=]]MedicationUseReasonForDiscontinuation</span>
|0..1
|0..1
|Reason why the use of a certain medicine was discontinued.
|Reason why the use of a certain medicine was discontinued.
Regel 215: Regel 228:
{|
{|
|-
|-
|[[Bestand: List2.png]]||[[#MedicationUseReasonForDiscontinuationCodelist|MedicationUseReasonForDiscontinuationCodelist]]
|[[Bestand: List2.png | link=#MedicationUseReasonForDiscontinuationCodelist]]||[[#MedicationUseReasonForDiscontinuationCodelist|MedicationUseReasonForDiscontinuationCodelist]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px]]
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.2.7
||NL-CM:9.2.7
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: MedicatieGebruikRedenVanOnderbreken">[[Bestand: arrowright.png | 10px]]MedicationUseReasonForInterruption</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11158 Title="NL: MedicatieGebruikRedenVanOnderbreken">[[Bestand: arrowright.png | 10px | link=]]MedicationUseReasonForInterruption</span>
|0..1
|0..1
|Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes.
|Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes.
Regel 228: Regel 241:
{|
{|
|-
|-
|[[Bestand: List2.png]]||[[#MedicationUseReasonForInterruptionCodelist|MedicationUseReasonForInterruptionCodelist]]
|[[Bestand: List2.png | link=#MedicationUseReasonForInterruptionCodelist]]||[[#MedicationUseReasonForInterruptionCodelist|MedicationUseReasonForInterruptionCodelist]]
|}
|}
|-style="vertical-align:top; background-color: transparent; "
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px]]
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.2.8
||NL-CM:9.2.8
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|<span Title="NL: Toelichting">[[Bestand: arrowright.png | 10px]]Comment</span>
|colspan ="5" style ="padding-left: 0px"|<span Id=11863 Title="NL: Toelichting">[[Bestand: arrowright.png | 10px | link=]]Comment</span>
|0..1
|0..1
|Comments on the medication use.
|Comments on the medication use.
Regel 248: Regel 261:
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 15%; color: #FFFFFF; font-weight: bold; "|GebruiksProduct
| style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font>
|colspan="4" style="background-color: #1F497D; width: 51%; color: #FFFFFF; font-weight: bold; "|GebruiksDosering
|colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font>
| style="background-color: #1F497D; width: 21%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruikStatus
| style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font>
| style="background-color: #1F497D; width: 13%; color: #FFFFFF; font-weight: bold; "|Voorschrift
| style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 15%; color: #FFFFFF; font-weight: bold; "|ProductNaam
| style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|StartDatum
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font>
| style="background-color: #548DD4; width: 10%; color: #FFFFFF; font-weight: bold; "|EindDatum
| style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font>
| style="background-color: #548DD4; width: 17%; color: #FFFFFF; font-weight: bold; "|Keerdosis <noWiki>|</noWiki> Toedieningsschema
| style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font>
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 13%; color: #FFFFFF; font-weight: bold; "|Reden van Voorschrijven
| style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 15%; "|
| style="background-color: #D9D9D9; width: 15%; "|
Regel 267: Regel 280:
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 13%; color: Black; font-weight: bold; "|Probleem
| style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 15%; "|Paracetamol tablet 500 mg
| style="width: 15%; "|Paracetamol tablet 500 mg
Regel 279: Regel 292:
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 15%; color: #FFFFFF; font-weight: bold; "|GebruiksProduct
| style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font>
|colspan="4" style="background-color: #1F497D; width: 51%; color: #FFFFFF; font-weight: bold; "|GebruiksDosering
|colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font>
| style="background-color: #1F497D; width: 21%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruikStatus
| style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font>
| style="background-color: #1F497D; width: 13%; color: #FFFFFF; font-weight: bold; "|Voorschrift
| style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 15%; color: #FFFFFF; font-weight: bold; "|ProductNaam
| style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|StartDatum
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font>
| style="background-color: #548DD4; width: 10%; color: #FFFFFF; font-weight: bold; "|EindDatum
| style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font>
| style="background-color: #548DD4; width: 17%; color: #FFFFFF; font-weight: bold; "|Keerdosis <noWiki>|</noWiki> Toedieningsschema
| style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font>
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 13%; color: #FFFFFF; font-weight: bold; "|Reden van Voorschrijven
| style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 15%; "|
| style="background-color: #D9D9D9; width: 15%; "|
Regel 298: Regel 311:
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 13%; color: Black; font-weight: bold; "|Probleem
| style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 15%; "|Pantoprazol injpdr 40mg fl
| style="width: 15%; "|Pantoprazol injpdr 40mg fl
Regel 310: Regel 323:
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
{|class="wikitable" width="975px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 15%; color: #FFFFFF; font-weight: bold; "|GebruiksProduct
| style="background-color: #1F497D; width: 15%; "|<font color=#FFFFFF><b>GebruiksProduct</b></font>
|colspan="4" style="background-color: #1F497D; width: 51%; color: #FFFFFF; font-weight: bold; "|GebruiksDosering
|colspan="4" style="background-color: #1F497D; width: 51%; "|<font color=#FFFFFF><b>GebruiksDosering</b></font>
| style="background-color: #1F497D; width: 21%; color: #FFFFFF; font-weight: bold; "|MedicatieGebruikStatus
| style="background-color: #1F497D; width: 21%; "|<font color=#FFFFFF><b>MedicatieGebruikStatus</b></font>
| style="background-color: #1F497D; width: 13%; color: #FFFFFF; font-weight: bold; "|Voorschrift
| style="background-color: #1F497D; width: 13%; "|<font color=#FFFFFF><b>Voorschrift</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 15%; color: #FFFFFF; font-weight: bold; "|ProductNaam
| style="background-color: #548DD4; width: 15%; "|<font color=#FFFFFF><b>ProductNaam</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|StartDatum
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>StartDatum</b></font>
| style="background-color: #548DD4; width: 10%; color: #FFFFFF; font-weight: bold; "|EindDatum
| style="background-color: #548DD4; width: 10%; "|<font color=#FFFFFF><b>EindDatum</b></font>
| style="background-color: #548DD4; width: 17%; color: #FFFFFF; font-weight: bold; "|Keerdosis <noWiki>|</noWiki> Toedieningsschema
| style="background-color: #548DD4; width: 17%; "|<font color=#FFFFFF><b>Keerdosis <noWiki>|</noWiki> Toedieningsschema</b></font>
| style="background-color: #548DD4; width: 12%; color: #FFFFFF; font-weight: bold; "|ToedieningsWeg
| style="background-color: #548DD4; width: 12%; "|<font color=#FFFFFF><b>ToedieningsWeg</b></font>
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 21%; "|
| style="background-color: #548DD4; width: 13%; color: #FFFFFF; font-weight: bold; "|Reden van Voorschrijven
| style="background-color: #548DD4; width: 13%; "|<font color=#FFFFFF><b>Reden van Voorschrijven</b></font>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 15%; "|
| style="background-color: #D9D9D9; width: 15%; "|
Regel 329: Regel 342:
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 21%; "|
| style="background-color: #D9D9D9; width: 13%; color: Black; font-weight: bold; "|Probleem
| style="background-color: #D9D9D9; width: 13%; "|<b>Probleem</b>
|-style=vertical-align:top;
|-style=vertical-align:top;
| style="width: 15%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
| style="width: 15%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
Regel 534: Regel 547:




==This information model in other releases==
<ul>
<li>[[MedicationUse-v1.0.1(2015EN) | Release 2015, (Version 1.0.1)]]</li>
</ul>
==More on this information model==
==More on this information model==
More technical information and HL7/XML documentation you can find on the Nictiz Art-Decor page about this information model[http://decor.nictiz.nl/art-decor/decor-datasets--zib1bbr-?id=2.16.840.1.113883.2.4.3.11.60.40.3.9.2] <BR>
To exchange information based on health and care information models, additional, more technical specifications are required.<BR>
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2016bbr-?id=2.16.840.1.113883.2.4.3.11.60.6.4.2.9.2&effectiveDate=2016-05-01T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=StructureDefinition [[File:fhir.png|link=]]]</li>
</ul>
This information model is also available as [[Media:nl.zorg.MedicationUse-v3.0(2016EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse-v3.0(2016EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
This information model is also available as [[Media:nl.zorg.MedicationUse-v3.0(2016EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.MedicationUse-v3.0(2016EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
==About this information==
The information in this wikipage is based on Release summer 2016 <BR>
The information in this wikipage is based on Release summer 2016 <BR>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
This page is generated on 28/09/2017 01:17:44 <BR>
This page is generated on 24/01/2018 23:30:14 <BR>
-----
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2016(EN)]] [[HCIM_Release_2016(EN) |Back to HCIM list ]]</div>
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2016(EN)]] [[HCIM_Release_2016(EN) |Back to HCIM list ]]</div>

Versie van 25 jan 2018 00:12

General information

Name: nl.zorg.MedicationUse NL.png
Version: 3.0
HCIM Status:Final
Release: 2016
Release status: Published
Release date: 1-5-2016

Back 16.png Back to HCIM list

Metadata

DCM::CoderList Kerngroep Registratie aan de Bron
DCM::ContactInformation.Address
DCM::ContactInformation.Name *
DCM::ContactInformation.Telecom
DCM::ContentAuthorList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::CreationDate 19-12-2013
DCM::DeprecatedDate
DCM::DescriptionLanguage nl
DCM::EndorsingAuthority.Address
DCM::EndorsingAuthority.Name PM
DCM::EndorsingAuthority.Telecom
DCM::Id 2.16.840.1.113883.2.4.3.11.60.40.3.9.2
DCM::KeywordList Medicatie, Feitelijk Gebruik, Gebruik
DCM::LifecycleStatus Final
DCM::ModelerList Kerngroep Registratie aan de Bron
DCM::Name nl.zorg.MedicatieGebruik
DCM::PublicationDate 1-5-2016
DCM::PublicationStatus Published
DCM::ReviewerList Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron
DCM::RevisionDate 22-5-2015
DCM::Superseeds nl.nfu.MedicatieGebruik-v1.0.1
DCM::Version 3.0
HCIM::PublicationLanguage EN

Revision History

Only available in Dutch

Publicatieversie 1.0 (01-04-2015)

ZIB-56 RFC Bouwsteen Medicatie
ZIB-308 Prefix Overdracht weggehaald bij de generieke bouwstenen

Incl. algemene wijzigingsverzoeken:

ZIB-94 Aanpassen tekst van Disclaimer, Terms of Use & Copyrights
ZIB-154 Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen.
ZIB-200 Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken.
ZIB-201 Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken.
ZIB-309 EOI aangepast
ZIB-324 Codelijsten Name en Description beginnen met een Hoofdletter
ZIB-326 Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015

Publicatieversie 1.0.1 (22-05-2015)

ZIB-381 Onterecht een spatie achter "OID :" in tagged value notes van tagged value DCM::ValueSet MedicatieGebruikRedenVanStoppenCodelijst van concept MedicatieGebruikRedenVanStoppen.

Publicatieversie 3.0 (01-05-2016)

.

Concept

MedicationUse describes taking or administering the medication, often in relation to a prescription, but also on the person’s own initiative. This describes the pattern of medication use, as reported by the patient themselves, a caregiver or healthcare provider. Documenting medication use provides insight into the use of prescribed medication as well as the use of medication at home.

Purpose

Recording medication information is a very important part of continuity in healthcare. It concerns the core of patient safety. Healthcare professionals in the collaborative branch must always have access to an up-to-date medication overview. Applying the information model will usually involve:
• Recording the patient’s intake of self-medication or ‘drugs’.
• Recording the medication used during a patient’s stay at the hospital.
• Medication verification: recording the active medication profile.

Information Model


MedicationPrescription-v3.0(2016EN)MedicationPrescription-v3.0(2016EN)#11150#MedicationUseReasonForInterruptionCodelist#11158#MedicationUseReasonForDiscontinuationCodelist#11159#MedicationUseStatusCodelistMedicationPrescription-v3.0(2016EN)#11154#11863MedicationUse-v3.0Model(EN).png


Type Id Concept Card. Definition DefinitionCode Reference
Block.png NL-CM:9.2.1 Arrowdown.pngMedicationUse Root concept of the MedicationUse information model. This root concept contains all data elements of the MedicationUse information model.
Verwijzing.png NL-CM:9.2.2 Arrowright.pngProductUsed::Product 1 The product used. This is usually medication. Food, blood products, aids and bandages do not strictly fall under the category of medication, but can be recorded as well.

In principle, this will be the prescribed product, but the product used may differ from the prescribed product.

Block.png MedicationPrescription
Verwijzing.png NL-CM:9.2.3 Arrowright.pngPrescription 0..* The agreement or order for the use of medication.
Block.png MedicationPrescription
Verwijzing.png NL-CM:9.2.4 Arrowright.pngUsedDosage::Dosage 0..* When taking stock of medication use, the dosage describes the amount and the pattern of use as reported by the patient or a healthcare provider.

The used dosage is the reported dose used by the patient. The used dosage may differ in terms of the administering schedule of the prescribed dosage in the event that the patient makes different decisions on their use of the product and reports as such.

Block.png MedicationPrescription
CD.png NL-CM:9.2.5 Arrowright.pngMedicationUseStatus 1 The status or status code is important in indicating the use schedule.

This attribute indicates whether the prescription is actively used, temporarily interrupted, or by now discontinued. Interrupting (home) use often occurs in the event of admittance to a healthcare facility, prior to a procedure and in response to monitoring (mirroring provisions, effect measurements, etc.).

When documenting this, the following interpretations are used:

  • Active: The product is used.
  • Interrupted: Use has (temporarily) been interrupted, because of a surgical procedure, for example. Later, the patient and/or doctor can decide whether or not to resume or discontinue use.
  • Discontinued: Use has been stopped for a specific reason.
  • Completed: Use has now been completed (according to the plan, prescription or agreement).]
  • Not started: The product was never used.
List2.png MedicationUseStatusCodelist
CD.png NL-CM:9.2.6 Arrowright.pngMedicationUseReasonForDiscontinuation 0..1 Reason why the use of a certain medicine was discontinued.
List2.png MedicationUseReasonForDiscontinuationCodelist
CD.png NL-CM:9.2.7 Arrowright.pngMedicationUseReasonForInterruption 0..1 Reason why the use of a certain medicine was interrupted. Here, you can choose to enter text or one of the codes.
List2.png MedicationUseReasonForInterruptionCodelist
ST.png NL-CM:9.2.8 Arrowright.pngComment 0..1 Comments on the medication use.

Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page List2.png

Example Instances

Only available in Dutch

GebruiksProduct GebruiksDosering MedicatieGebruikStatus Voorschrift
ProductNaam StartDatum EindDatum Keerdosis | Toedieningsschema ToedieningsWeg Reden van Voorschrijven
Probleem
Paracetamol tablet 500 mg 05-2012 Zo nodig 500mg (=1st), max. 4x/dag Oraal Actief Hoofdpijn
GebruiksProduct GebruiksDosering MedicatieGebruikStatus Voorschrift
ProductNaam StartDatum EindDatum Keerdosis | Toedieningsschema ToedieningsWeg Reden van Voorschrijven
Probleem
Pantoprazol injpdr 40mg fl 11-09-2012 17:21 1x/dag(8u) 40mg (=1st) iv Actief Ulcusprofylaxe
GebruiksProduct GebruiksDosering MedicatieGebruikStatus Voorschrift
ProductNaam StartDatum EindDatum Keerdosis | Toedieningsschema ToedieningsWeg Reden van Voorschrijven
Probleem
Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml 19-09-2012 1x/dag(18u) 2500ie(=0,2ml) Subcutaan Actief Thrombose-
profylaxe

References

1. GROOT, E. (2011) Dataset medicatieproces 2011. [Online] Den Haag: Nictiz. Beschikbaar op: http://www.nictiz.nl/module/360/590/Dataset_Medicatieproces_2011.xlsx [Geraadpleegd: 23 juli 2014].

2. HL7v3-implementatiehandleiding medicatieproces versie 6.1.0.0. [Online] Den Haag: Nictiz. Beschikbaar op: http://www.nictiz.nl/uploaded/FILES/html_cabinet/live/Zorgtoepassing/Medicatieproces/AORTA_Mp_IH_Medicatieproces_HL7.htm [Geraadpleegd: 23 juli 2014].

3. Dossier Medicatieoverzicht. [Online] Beschikbaar op: Oria.nl. [Geraadpleegd: 23 juli 2014].

4. G-standaard documentatie. [Online] Beschikbaar op: http://www.z-index.nl/ [Geraadpleegd: 23 juli 2014].

Valuesets

MedicationUseReasonForDiscontinuationCodelist

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.2
Conceptname Conceptcode Codesystem name Codesystem OID Description
Intolerance SINTOL ActReason 2.16.840.1.113883.5.8 Bijwerking, allergie of intolerantie
Condition alert COND ActCode 2.16.840.1.113883.5.4 Contra-indicatie
Drug interacts with another drug SDDI ActReason 2.16.840.1.113883.5.8 Interactie met ander medicament
Dose change DOSECHG ActReason 2.16.840.1.113883.5.8 Dosiswijziging
No longer required for treatment NOREQ ActReason 2.16.840.1.113883.5.8 Niet langer vereist voor de behandeling
Ineffective INEFFECT ActReason 2.16.840.1.113883.5.8 Niet effectief
Formulary policy FP ActReason 2.16.840.1.113883.5.8 Ander voorschrijfbeleid
Product discontinued DISCONT ActReason 2.16.840.1.113883.5.8 Product niet meer leverbaar
Not covered NOTCOVER ActReason 2.16.840.1.113883.5.8 Product wordt niet vergoed
Patient refuse PREFUS ActReason 2.16.840.1.113883.5.8 Patiënt heeft geweigerd

MedicationUseReasonForInterruptionCodelist

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.3
Conceptname Conceptcode Codesystem name Codesystem OID Description
Drug level too high DRUGHIGH ActReason 2.16.840.1.113883.5.8 Te hoge geneesmiddel spiegel
Lab interference issues LABINT ActReason 2.16.840.1.113883.5.8 Interferentie met gepland labonderzoek
Patient is pregnant/breast feeding PREG ActReason 2.16.840.1.113883.5.8 Patiënt is zwangerschap of geeft borstvoeding
Patient not-available NON-AVAIL ActReason 2.16.840.1.113883.5.8 Patiënt is niet beschikbaar
Response to monitoring MONIT ActReason 2.16.840.1.113883.5.8 Reactie op monitoring
Drug interacts with another drug SDDI ActReason 2.16.840.1.113883.5.8 Interactie met ander medicament
Duplicate therapy SDUPTHER ActReason 2.16.840.1.113883.5.8 Een andere therapie maakt het gebruik tijdelijk overbodig
Patient scheduled for surgery SURG ActReason 2.16.840.1.113883.5.8 Patient is ingepland voor een ingreep
Waiting for old drug to wash out WASHOUT ActReason 2.16.840.1.113883.5.8 Tijdelijk onderbreken tot ander geneesmiddel geen werking meer uitoefent

MedicationUseStatusCodelist

Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.2.1
Conceptname Conceptcode Codesystem name Codesystem OID Description
Active active ActStatus 2.16.840.1.113883.5.14 Actief
Suspended suspended ActStatus 2.16.840.1.113883.5.14 Onderbroken
Aborted aborted ActStatus 2.16.840.1.113883.5.14 Afgebroken
Completed completed ActStatus 2.16.840.1.113883.5.14 Voltooid
Cancelled cancelled ActStatus 2.16.840.1.113883.5.14 Niet gestart


This information model in other releases

More on this information model

To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:

  • HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment Artdecor.jpg
  • HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR Fhir.png

This information model is also available as pdf file PDF.png or as spreadsheet Xlsx.png

About this information

The information in this wikipage is based on Release summer 2016
Conditions for use are located on the mainpage List2.png
This page is generated on 24/01/2018 23:30:14

Back 16.png Back to HCIM list
Overgenomen van "https://zibs.test-nictiz.nl/index.php?title=MedicationUse-v3.0(2016EN)&oldid=9749"